Page last updated: 2024-08-21

nicotinamide mononucleotide and bortezomib

nicotinamide mononucleotide has been researched along with bortezomib in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Cetinkaya-Fisgin, A; Cheng, GC; DiAntonio, A; Doan, RA; Geisler, S; Höke, A; Huang, SX; Milbrandt, J	1

Other Studies

1 other study(ies) available for nicotinamide mononucleotide and bortezomib

Article	Year
Vincristine and bortezomib use distinct upstream mechanisms to activate a common SARM1-dependent axon degeneration program. JCI insight, 2019, 09-05, Volume: 4, Issue:17 Topics: Animals; Antineoplastic Agents; Apoptosis; Armadillo Domain Proteins; Axons; Bortezomib; Cytoskeletal Proteins; Drug Therapy; Female; Gene Expression Regulation, Neoplastic; Genetic Therapy; Humans; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Nerve Degeneration; Neurons; Nicotinamide Mononucleotide; Nicotinamide-Nucleotide Adenylyltransferase; Vincristine	2019

Article

Year

Vincristine and bortezomib use distinct upstream mechanisms to activate a common SARM1-dependent axon degeneration program.

JCI insight, 2019, 09-05, Volume: 4, Issue:17

Topics: Animals; Antineoplastic Agents; Apoptosis; Armadillo Domain Proteins; Axons; Bortezomib; Cytoskeletal Proteins; Drug Therapy; Female; Gene Expression Regulation, Neoplastic; Genetic Therapy; Humans; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Nerve Degeneration; Neurons; Nicotinamide Mononucleotide; Nicotinamide-Nucleotide Adenylyltransferase; Vincristine

2019